SCHILKE TOBIN (Chief Financial Officer) reported 2 transactions at CRINETICS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/1/2026ACC: 0001628280-26-059883
Officer· Chief Financial Officer
Since Mar 2026
-209.43K
Net shares
Net seller
$6.75M
Total sold
0
Open market trades
0B · 0S
4
Total transactions
209.43K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.96K
Price / share
$85.00
Trade value
$676.26K
% of position
10.0%
9/1/2026
79.43K→71.47K
Common Stock
Direct
Shares
−71.47K
Price / share
$85.00
Trade value
$6.08M
% of position
New position
9/1/2026
71.47K→0.00
Total
Net shares
−79.43K
Net value
-$6.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | D · Disposition | −7.96K | $85.00 | $676.26K | 10.0% | 79.43K | 71.47K |
| Common Stock Direct | 9/1/2026 | D · Disposition | −71.47K | $85.00 | $6.08M | New position | 71.47K | 0.00 |
| Total | −79.43K | -$6.75M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
80K shares
Shares
−80K
Strike price
33.75
Held after
0.00
Exercisable
—
9/1/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
43.79
Held after
0.00
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock80K shares | 9/1/2026 | D · Disposition | −80K | 33.75 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 9/1/2026 | D · Disposition | −50K | 43.79 | — | 0.00 |